Archrock delivered a second-quarter print on August 4, 2026 that, on the surface, looked like a clean hold-pattern quarter: revenue of $371.2 million was down 3% year-over-year, but Adjusted EBITDA of $212.6 million was essentially flat at $212.7 million in the prior-year quarter, and earnings per share of $0.38 expanded 6% from $0.36 as buybacks and lower share counts lifted the bottom line. The market read the print as a modest beat on the cost side and a modest miss on the top line, then promptly looked past both because the more consequential disclosure was sitting in the management commentary: a fresh multi-year growth capital expenditure envelope of $1.4 billion to $1.6 billion cumulatively from 2027 through 2030, a tightening of full-year 2026 Adjusted EBITDA guidance to $865 million to $885 million from the prior $865 million to $915 million, and a long-term compression services agreement covering roughly 665,000 horsepower with an existing strategic customer over an eight-year base term.
The mechanism behind the equity story is straightforward once the prints are lined up against the balance sheet: the H1 2026 cash flow statement shows operating cash flow of $346.6 million against capital expenditures of $211.4 million, producing free cash flow of roughly $135 million in six months, with the cash returned to shareholders through $78.5 million of dividends and a residual $4.4 million of share repurchases. Long-term debt sits at $2.35 billion against stockholders' equity of $1.55 billion and an Adjusted EBITDA run-rate tracking toward $870 million, putting leverage at 2.6 times, a clean improvement from 3.3 times a year ago. The thesis is that Archrock is one of the few U.S.-listed large-cap natural gas compression services platforms with a sector-leading balance sheet, a contracted backlog that just got a fresh 665,000-horsepower anchor through 2034, and the operating cash conversion to fund a doubling of growth capital spending through the end of the decade without a return to the high-leverage posture of 2024 and 2025.
The single load-bearing risk is that the new growth capital envelope, the $250 million to $275 million of 2026 growth capital expenditures that funds it, and the lube oil and aftermarket cost pressures that triggered the guidance tightening are all happening at the same time the equity is priced for compression demand to stay structurally tight and for Archrock's contract economics to keep expanding. The second-half 2026 cost build absorbs the guidance cut, the $868 million purchase commitment pipeline shows the fleet expansion is contractually committed, and the $1.5 billion remaining performance obligation backlog is the visibility the buy-side wants to see. The market is, in our view, mostly pricing the cash flow durability through 2030 rather than the 2026 quarterly cadence, and the next two prints are the test of whether the cost pressures stabilize or whether the second-half 2026 guide is a leading indicator of a more durable margin step-down as growth capex accelerates into 2027.